Symposia: Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological
	
	
	Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Bleeding and Clotting, epidemiology, Clinical Research, Genetic Disorders, Diseases, thrombocytopenias, thrombotic disorders, registries, survivorship
	Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Bleeding and Clotting, epidemiology, Clinical Research, Genetic Disorders, Diseases, thrombocytopenias, thrombotic disorders, registries, survivorship
Monday, December 11, 2023: 10:30 AM-12:00 PM
	Room 29 
		(San Diego Convention Center)
	
	
	
	
	   
	
	
			
		Moderators:
			
				
				
					
						
						
						
							Pavan K Bendapudi, MD, Beth Israel Deaconess Medical Center
						
					
					
				
					
						 and 
						
						
							Radhika Gangaraju, MD, University Of Alabama
						
					
					
				
			
 
			
			Disclosures:
			
			
				
			
				
			
			Bendapudi: Takeda Pharmaceuticals: Consultancy; Alexion Pharmaceuticals: Consultancy. Gangaraju: Sanofi Genzyme: Consultancy, Honoraria; Alexion: Consultancy; Takeda: Consultancy. 
			 
		Oral abstracts in this session discuss population prevalence and recombinant ADAMTS13 for congenital TTP, provide insights into the kinetics of ADAMTS13 recovery in reponse to targeted therapies in immune TTP, and subclinical cardiac disease in immune TTP survivors.
		
		
	
	10:30 AM
	
	
10:45 AM
	
	
11:00 AM
	
	
11:30 AM
	
	
11:45 AM
	
	
	
	
	See more of: Oral and Poster Abstracts
	
	
	
	
	*signifies non-member of ASH
					 
	
	 denotes an abstract that is clinically relevant.
 denotes an abstract that is clinically relevant. denotes that this is a recommended PHD Trainee Session.
 denotes that this is a recommended PHD Trainee Session. denotes that this is a ticketed session.
 denotes that this is a ticketed session.